| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18831523 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 101 journal articles in the PubMed database | Email to a friend | | |
| Malesci A, Angelucci E, Bonifacio C, et al.
Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2008 Oct 2.
Full Citation | Find Related Articles | | Behm BW, Bickston SJ
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. [Journal Article, Review]
Cochrane Database Syst Rev 2008; (1):CD006893.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hanauer SB, Sandborn WJ, Rutgeerts P, et al.
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. [Journal Article, Multicenter Study, Randomized Controlled Trial]
Gastroenterology 2006 Feb; 130(2):323-33; quiz 591.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Peyrin-Biroulet L, Deltenre P, de Suray N, et al.
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. [Journal Article, Research Support, Non-U.S. Gov't]
Clin Gastroenterol Hepatol 2008 Jun; 6(6):644-53.
Abstract | Full Citation | Find Related Articles | | Asteria CR, Ficari F, Bagnoli S, et al.
Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: A pilot study. [Journal Article]
Scand J Gastroenterol 2006 Sep; 41(9):1064-72.
Abstract | Full Citation | Find Related Articles | | Sandborn WJ
Strategies for targeting tumour necrosis factor in IBD. [Journal Article, Review]
Best Pract Res Clin Gastroenterol 2003 Feb; 17(1):105-17.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hinojosa J, Gomollón F, García S, et al.
Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial. [Journal Article]
Aliment Pharmacol Ther 2007 Feb 15; 25(4):409-18.
Abstract | Full Citation | Find Related Articles | | Sandborn WJ, Hanauer S, Loftus EV, et al.
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease. [Clinical Trial, Clinical Trial, Phase II, Journal Article]
Am J Gastroenterol 2004 Oct; 99(10):1984-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Poritz LS, Rowe WA, Koltun WA
Remicade does not abolish the need for surgery in fistulizing Crohn's disease. [Journal Article]
Dis Colon Rectum 2002 Jun; 45(6):771-5.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
